Literature DB >> 31059864

Time course of rapid bone loss and cortical porosity formation observed by longitudinal μCT in a rat model of CKD.

Erin M B McNerny1, Dorothy T Buening2, Mohammad W Aref1, Neal X Chen3, Sharon M Moe4, Matthew R Allen5.   

Abstract

BACKGROUND: Rodent studies of bone in chronic kidney disease have primarily relied on end-point examinations of bone microarchitecture. This study used longitudinal in vivo microcomputed tomography (in vivo μCT) to characterize the onset and progression of bone loss, specifically cortical porosity, in the Cy/+ rat of model of CKD.
METHODS: Male CKD rats and normal littermates were studied. In vivo μCT scans of the right distal tibia repeated at 25, 30, and 35 weeks were analyzed for longitudinal changes in cortical and trabecular bone morphometry. In vitro μCT scans of the tibia and femur identified spatial patterns of bone loss across distal, midshaft and proximal sites.
RESULTS: CKD animals had reduced BV/TV and cortical BV at all time points but developed cortical porosity and thinning between 30 and 35 weeks. Cortical pore formation was localized near the endosteal surface. The severity of bone loss was variable across bone sites, but the distal tibia was representative of both cortical and trabecular changes.
CONCLUSIONS: The distal tibia was found to be a sensitive suitable site for longitudinal imaging of both cortical and trabecular bone changes in the CKD rat. CKD trabecular bone loss progressed through ~30 weeks followed by a sudden acceleration in cortical bone catabolism. These changes varied in timing and severity across individuals, and cortical bone loss and porosity progressed rapidly once initiated. The inclusion of longitudinal μCT in future studies will be important for both reducing the number of required animals and to track individual responses to treatment.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CKD-MBD; In vivo microcomputed tomography; Longitudinal imaging; Rat models; Renal osteodystrophy

Mesh:

Year:  2019        PMID: 31059864      PMCID: PMC6581598          DOI: 10.1016/j.bone.2019.05.002

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  37 in total

1.  Monitoring individual morphological changes over time in ovariectomized rats by in vivo micro-computed tomography.

Authors:  Steven K Boyd; Peter Davison; Ralph Müller; Jürg A Gasser
Journal:  Bone       Date:  2006-06-06       Impact factor: 4.398

Review 2.  The role of cortical bone and its microstructure in bone strength.

Authors:  Peter Augat; Sandra Schorlemmer
Journal:  Age Ageing       Date:  2006-09       Impact factor: 10.668

Review 3.  Application of micro-CT in small animal imaging.

Authors:  Sebastian J Schambach; Simona Bag; Lothar Schilling; Christoph Groden; Marc A Brockmann
Journal:  Methods       Date:  2009-08-23       Impact factor: 3.608

4.  A rat model of chronic kidney disease-mineral bone disorder.

Authors:  Sharon M Moe; Neal X Chen; Mark F Seifert; Rachel M Sinders; Dana Duan; Xianming Chen; Yun Liang; J Scott Radcliff; Kenneth E White; Vincent H Gattone
Journal:  Kidney Int       Date:  2008-09-17       Impact factor: 10.612

5.  Bone mass and microarchitecture in CKD patients with fracture.

Authors:  Thomas L Nickolas; Emily Stein; Adi Cohen; Valerie Thomas; Ronald B Staron; Donald J McMahon; Mary B Leonard; Elizabeth Shane
Journal:  J Am Soc Nephrol       Date:  2010-04-15       Impact factor: 10.121

6.  Noninvasive in vivo monitoring of bone architecture alterations in hindlimb-unloaded female rats using novel three-dimensional microcomputed tomography.

Authors:  Valentin David; Norbert Laroche; Benjamin Boudignon; Marie-Hélène Lafage-Proust; Christian Alexandre; Peter Ruegsegger; Laurence Vico
Journal:  J Bone Miner Res       Date:  2003-09       Impact factor: 6.741

7.  Detecting and tracking local changes in the tibiae of individual rats: a novel method to analyse longitudinal in vivo micro-CT data.

Authors:  J H Waarsing; J S Day; J C van der Linden; A G Ederveen; C Spanjers; N De Clerck; A Sasov; J A N Verhaar; H Weinans
Journal:  Bone       Date:  2004-01       Impact factor: 4.398

8.  Bone imaging and chronic kidney disease: will high-resolution peripheral tomography improve bone evaluation and therapeutic management?

Authors:  Justine Bacchetta; Stéphanie Boutroy; Laurent Juillard; Nicolas Vilayphiou; Fitsum Guebre-Egziabher; Solenne Pelletier; Pierre D Delmas; Denis Fouque
Journal:  J Ren Nutr       Date:  2009-01       Impact factor: 3.655

9.  R-568 reduces ectopic calcification in a rat model of chronic kidney disease-mineral bone disorder (CKD-MBD).

Authors:  Sharon M Moe; Mark F Seifert; Neal X Chen; Rachel M Sinders; Xianming Chen; Dana Duan; Charles Henley; Dave Martin; Vincent H Gattone
Journal:  Nephrol Dial Transplant       Date:  2009-03-03       Impact factor: 5.992

10.  Effects of PTH treatment on tibial bone of ovariectomized rats assessed by in vivo micro-CT.

Authors:  J E M Brouwers; B van Rietbergen; R Huiskes; K Ito
Journal:  Osteoporos Int       Date:  2009-03-05       Impact factor: 4.507

View more
  15 in total

1.  The combination of aging and chronic kidney disease leads to an exacerbated cortical porosity phenotype.

Authors:  Samantha P Tippen; Corinne E Metzger; Elizabeth A Swallow; Spencer A Sacks; Joseph M Wallace; Matthew R Allen
Journal:  Bone       Date:  2021-10-05       Impact factor: 4.398

2.  Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD.

Authors:  Annabel Biruete; Corinne E Metzger; Neal X Chen; Elizabeth A Swallow; Curtis Vrabec; Erica L Clinkenbeard; Alexander J Stacy; Shruthi Srinivasan; Kalisha O'Neill; Keith G Avin; Matthew R Allen; Sharon M Moe
Journal:  Nephrol Dial Transplant       Date:  2022-09-22       Impact factor: 7.186

Review 3.  Kidney Disease and Bone: Changing the Way We Look at Skeletal Health.

Authors:  Matthew R Allen; Elizabeth A Swallow; Corinne E Metzger
Journal:  Curr Osteoporos Rep       Date:  2020-06       Impact factor: 5.096

Review 4.  Transcriptomics: a Solution for Renal Osteodystrophy?

Authors:  Aline Martin; Valentin David
Journal:  Curr Osteoporos Rep       Date:  2020-06       Impact factor: 5.096

5.  Elevations in Cortical Porosity Occur Prior to Significant Rise in Serum Parathyroid Hormone in Young Female Mice with Adenine-Induced CKD.

Authors:  Corinne E Metzger; Elizabeth A Swallow; Matthew R Allen
Journal:  Calcif Tissue Int       Date:  2019-12-12       Impact factor: 4.333

6.  Using micro computed tomographic imaging for analyzing kidney stones.

Authors:  James C Williams; James E Lingeman; Michel Daudon; Dominique Bazin
Journal:  C R Chim       Date:  2021-06-29       Impact factor: 3.117

7.  Strain-specific alterations in the skeletal response to adenine-induced chronic kidney disease are associated with differences in parathyroid hormone levels.

Authors:  Corinne E Metzger; Elizabeth A Swallow; Alexander J Stacy; Matthew R Allen
Journal:  Bone       Date:  2021-04-17       Impact factor: 4.626

8.  MicroRNA-130a controls bone marrow mesenchymal stem cell differentiation towards the osteoblastic and adipogenic fate.

Authors:  Zhangyuan Lin; Hongbo He; Min Wang; Jieyu Liang
Journal:  Cell Prolif       Date:  2019-09-26       Impact factor: 6.831

9.  N-acetylcysteine (NAC), an anti-oxidant, does not improve bone mechanical properties in a rat model of progressive chronic kidney disease-mineral bone disorder.

Authors:  Matthew R Allen; Joseph Wallace; Erin McNerney; Jeffry Nyman; Keith Avin; Neal Chen; Sharon Moe
Journal:  PLoS One       Date:  2020-03-23       Impact factor: 3.240

10.  Longitudinal Evolution of Bone Microarchitecture and Bone Strength in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures-A 5-Year Follow-Up Study Using High Resolution Peripheral Quantitative Computed Tomography.

Authors:  Ursula Heilmeier; Gabby B Joseph; Courtney Pasco; Nhan Dinh; Soheyla Torabi; Karin Darakananda; Jiwon Youm; Julio Carballido-Gamio; Andrew J Burghardt; Thomas M Link; Galateia J Kazakia
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-16       Impact factor: 6.055

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.